Ganga Reddy Velma

Researcher/Scientist III
vgreddy@arizona.edu

Dr. Velma joined the University of Arizona in January 2021 as a Postdoctoral Research Associate where he actively involved in the SARS-CoV-2, Triple-negative Breast Cancer (TNBC), AD and Type 2 diabetes (T2D) drug discovery projects. For the last 10 years, he involved in various lead discovery projects in the field of medicinal chemistry and also developed efficient methodologies for the construction of organic frameworks, C-C, C-N, and C-O bond formation reactions which allow new synthetic routes for the preparation of bioactive heterocyclic molecules. Skilled in lead designing, executing multi-step organic synthesis, small heterocyclic molecules (gram scale to mg scale), and purification of high-quality target molecules for various therapeutic applications.

Patents: Ahmed Kamal, V. Ganga Reddy, R. Syed, S. B. Korrapati, Poornachandra Yedla, Ganesh Kumar Chityal, (E)-4-(4-acrylamidophenoxy)-N-methylpicolinamide conjugates as potential anticancer agents. US11174230B2, WO2017/125946 A1 (PCT/IN2017/050004) EP3405457B1

Ahmed Kamal, V. Ganga Reddy, A. V. Subba Rao, Sd. Riyaz, V. Lakshma Nayak, Shaik Taj, 4Beta-Amidotriazole Linked Podophyllotoxin Derivatives as Potential Anticancer Agents.  
US10947248B2, WO 2017/154026 A1 (WO: PCT/IN2017/050088) EP 3426661 A1 

 

Degree(s)

  • Postdoctoral Research Associate, University of Arizona, Tucson, USA, 2023
  • Postdoctoral Fellow, RMIT-University, Melbourne, Australia, 2020
  • PhD, CSIR-Indian Institute of Chemical Technology, Hyderabad, India 2019
  • Msc, Osmania University, Hyderabad, India, 2011
  • BSc, Osmania University, Hyderabad, India, 2009